Neurodegeneration with brain iron accumulation (NBIA) is a heterogeneous group (genetically and phenotypically) of genetically determined disorders. Up to date there is no cure for this disease, so the applied treatments focus on symptoms control and palliative care. The main problems are delayed motor development, gait deterioration, postural instability, cognitive dysfunctions, abnormal muscle tone and many others. As gait and balance deficits are predominant features of NBIA patients this study aimed at the use of the objective, instrumented functional tests as well as functional assessment scales to assess their functional impairments. Twenty three NBIA patients recruited for the study underwent objective, instrumented gait analysis, balance assessment, pedobarography and functional evaluation with Gross Motor Function Measure (GMFM-88). The results showed high variability and heterogeneity of NBIA functional status (GMFM from 27.5 to 100.0), but also showed some differences in gait pattern between their types ( < 0.05 at the pelvis, hip and knee). We think that these results could help design objective assessment protocols in future clinical studies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350201PMC
http://dx.doi.org/10.5582/irdr.2024.01019DOI Listing

Publication Analysis

Top Keywords

nbia patients
12
functional impairments
8
objective instrumented
8
functional
6
nbia
5
impairments nbia
4
patients preliminary
4
preliminary neurodegeneration
4
neurodegeneration brain
4
brain iron
4

Similar Publications

Pathology and treatment methods in pantothenate kinase-associated neurodegeneration.

Postep Psychiatr Neurol

September 2024

Independent Public Health Care Institution named after doctor Kazimierz Hołoga, Nowy Tomyśl, Poland.

Purpose: The purpose of this review is to present current scientific reports on the pathophysiology, diagnosis and treatment of pantothenate kinase-associated neurodegeneration (PKAN).

Views: The condition is caused by a mutation in the PANK2 gene, which results in iron accumulation in the brain and changes in the functioning of biochemical pathways dependent on coenzyme A. There are two clinical types of PKAN, which differ in the time of onset of symptoms and speed of disease progression.

View Article and Find Full Text PDF
Article Synopsis
  • - Neurodegeneration with brain iron accumulation 5 (NBIA5) is caused by mutations in the WDR45 gene and is inherited in an X-linked fashion.
  • - The study presents three Iranian patients with distinct mutations in the WDR45 gene, identified through whole-exome sequencing, including c.697 C>T, c.657_658del, and c.1004_1005del.
  • - Hypothyroidism was found in two of the cases, and overall, the clinical features were consistent with existing literature, highlighting the genetic diversity of this disorder in the Iranian population.
View Article and Find Full Text PDF
Article Synopsis
  • * The diagnosis of PKAN relies on clinical observations, a specific brain MRI finding called the "eye of the tiger," and genetic testing for mutations in the pantothenate kinase 2 (PANK2) gene, which plays a crucial role in coenzyme A (CoA) production.
  • * Research shows that combining multitarget supplements (like pantothenate, pantethine, omega-3, and vitamin E) with standard
View Article and Find Full Text PDF

Neurodegeneration with brain iron accumulation (NBIA) is a genetic disorder characterized by iron accumulation in the basal ganglia. Patients may develop behavioral abnormalities, dementia, movement disorders, and neuropsychiatric symptoms such as emotional lability, depression, anxiety, hallucinations, impulsivity, obsessions, and hyperactivity. In this case, a 46-year-old male patient with a C19orf12 mutation experienced depressive complaints before movement disorders, followed by cognitive deficits and psychotic symptoms as the disease progressed.

View Article and Find Full Text PDF

Neurodegeneration with brain iron accumulation (NBIA) is a group of rare neurodegenerative diseases characterized by iron accumulation in the brain. Mitochondrial membrane protein-associated neurodegeneration (MPAN) is a subtype of NBIA caused by an autosomal recessive mutation in the C19orf12 gene. In this work, we generated and characterized four lines of human induced pluripotent stem cell (hiPSCs) derived from dermal fibroblasts of patients carrying homozygous mutation c.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!